We will discuss 3 new classes of cancer drugs: antibody drug conjugates, checkpoint inhibitors and MEK inhibitors and how they affect the eyes
Almost 800 attended our event and we received amazing feedback!
Feedback from anonymous survey:
Love that she started with case studies/examples
Thank you Dr. it was a brand new topic for me, very informative!
Great topic with an interesting presentation.
Best lecture of the three in the ADC series
What a great lecture-well organized!
wonderful coverage of an important update thank you
Timely and excellent information
Speaker was super knowledgeable! Interesting topic.
Lots of new material
PHENOMENAL SPEAKER!!! AWESOME LECTURE!
Lots of new material
Dr. Canestraro presentation was engaging and easy to follow!!
Very interesting and helpful information since cancer is a growing problem and many people are taking these meds for treatment.
Speaker: Dr. Julia Canestraro
Thank you to ImmunoGen for supporting this event with unrestricted educational grant.
This event is COPE approved for 1 hour of continuing education credit.